Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Oral acyclovir induced hypokalemia and acute tubular necrosis a case report

Authors: Jonathan S. Chávez-Iñiguez, Ramón Medina-Gonzalez, Lilia Aguilar-Parra, Eduardo J. Torres-Vázquez, Pablo Maggiani-Aguilera, Enrique Cervantes-Pérez, Guillermo García-García

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Acyclovir is one of the most common prescribed antiviral drugs. Acyclovir nephrotoxicity occurs in approximately 12–48% of cases. It can present in clinical practice as acute kidney injury (AKI), crystal-induced nephropathy, acute tubulointerstitial nephritis, and rarely, as tubular dysfunction. Electrolytes abnormalities like hypokalemia, were previously described only when given intravenously.

Case presentation

A 54 year-old female presented with weakness and lower extremities paresis, nausea and vomiting after receiving oral acyclovir. Physical examination disclosed a decrease in the patellar osteotendinous reflexes (++ / ++++). Laboratory data showed a serum creatinine level of 2.1 mg/dL; serum potassium 2.1 mmol/L. Kidney biopsy was obtained; histological findings were consistent with acute tubular necrosis and acute tubulointerstitial nephritis. The patient was advised to stop the medications and to start with oral and intravenous potassium supplement, symptoms improved and continued until serum potassium levels were > 3.5 meq/L.

Conclusions

The case reported in this vignette is unique since it is the first one to describe hypokalemia associated to acute tubular necrosis induced by oral acyclovir.
Literature
1.
go back to reference Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis. 2005;45(5):804–17.CrossRef Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis. 2005;45(5):804–17.CrossRef
8.
9.
go back to reference Edwards CR, Walker BR, Benediktsson R, Seckl JR. Congenital and acquired syndromes of apparent mineralocorticoid excess. J Steroid Biochem Mol Biol. 1993;45:1–5.CrossRef Edwards CR, Walker BR, Benediktsson R, Seckl JR. Congenital and acquired syndromes of apparent mineralocorticoid excess. J Steroid Biochem Mol Biol. 1993;45:1–5.CrossRef
10.
go back to reference Meyers AM, Feldman C, Sonnekus MI, Ninin DT, Margolius LP, Whalley NA. Chronic laxative abusers with pseudoidiopathic oedema and autonomous pseudo-Bartter's syndrome: a spectrum of metabolic madness, or new lights on an old disease. S Afr Med J. 1990;78:631–6.PubMed Meyers AM, Feldman C, Sonnekus MI, Ninin DT, Margolius LP, Whalley NA. Chronic laxative abusers with pseudoidiopathic oedema and autonomous pseudo-Bartter's syndrome: a spectrum of metabolic madness, or new lights on an old disease. S Afr Med J. 1990;78:631–6.PubMed
11.
go back to reference Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med. 1992;86:419–23.CrossRef Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med. 1992;86:419–23.CrossRef
12.
go back to reference Bradberry SM. Vale JA disturbances of potassium homeostasis in poisoning. J Toxicol Clin Toxicol. 1995;33(4):295–310.CrossRef Bradberry SM. Vale JA disturbances of potassium homeostasis in poisoning. J Toxicol Clin Toxicol. 1995;33(4):295–310.CrossRef
Metadata
Title
Oral acyclovir induced hypokalemia and acute tubular necrosis a case report
Authors
Jonathan S. Chávez-Iñiguez
Ramón Medina-Gonzalez
Lilia Aguilar-Parra
Eduardo J. Torres-Vázquez
Pablo Maggiani-Aguilera
Enrique Cervantes-Pérez
Guillermo García-García
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1121-0

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue